Dear Colleagues, dear Friends,
I am happy to invite you again to the international symposium ACUTE LEUKEMIAS XIX (ISALXIX) – the hematology event in spring 2025 for all healthcare professionals active in the field of acute leukemias. Don’t miss this opportunity to collect again invaluable educational experience by simultaneously actively participating as a free contributor of your scientific abstract, highlighting the most recent findings and updates thus rendering and gaining invaluable new insights in the latest study results and treatment measures.
The symposium is taking place in Munich in-person from Sunday, March 16 until Wednesday, March 19, 2025, and is addressing all healthcare professionals (HCPs) as well as all healthcare organizations (HCOs) and patients' organizations (POs) active in the field of acute leukemias.
The focus of the symposium will be on the following key areas:
- MS I: Biology of Acute Leukemias
- MS II: Biology in Acute Leukemias
- MS III: Genetic and Molecular Characterization of AML: Novel Markers for Diagnosis and Prognosis
- MS IV: Novel Approaches and Targeted Therapies in AML
- MS VI: Risk adapted Therapy of AML
- MS VII: Biology and Treatment of APL
- MS VIII: MRD in Acute Leukemias: Methods and Clinical Applications
- MS X: Immunotherapy for Acute Leukemias
- MS XI: ALL: Biology and Treatment Strategies
Satellite Symposia and Meet-the-Expert Sessions will deliver further chances to discuss advances and perspectives of basic science and treatment strategies.
The two free contributions sessions - MS V: Poster session and MS IX: Best of Free Contributions Session - will additionally deliver the possibility to all those who want to present their own research data and discuss their findings with the worldwide most renowned scientists and researchers in the field of acute leukemias.
We look forward to welcoming you in-person in Munich March 2025.
Yours
W. Hiddemann
Chairman ISALXIX